logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 2
  • 1
    Gradillas Gonzalez, Vicente, Dr
    Born in August 1972
    Individual (16 offsprings)
    Officer
    2020-05-06 ~ now
    OF - Director → CIF 0
    Dr Vicente Gradillas Gonzalez
    Born in August 1972
    Individual (16 offsprings)
    Person with significant control
    2020-05-06 ~ now
    PE - Has significant influence or controlCIF 0
  • 2
    44, Esplanade, St Helier, Jersey
    Corporate (1 offspring)
    Person with significant control
    2020-10-30 ~ now
    PE - Right to appoint or remove directorsCIF 0
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

CLAIMONT PHARMA LTD

Previous name
CLAYMONT LIMITED - 2020-06-16
Standard Industrial Classification
72190 - Other Research And Experimental Development On Natural Sciences And Engineering
Brief company account
Debtors
297 GBP2024-06-30
14,898 GBP2023-06-30
Cash at bank and in hand
18,291 GBP2024-06-30
8,742 GBP2023-06-30
Current Assets
18,588 GBP2024-06-30
23,640 GBP2023-06-30
Net Current Assets/Liabilities
-77,684 GBP2024-06-30
-76,186 GBP2023-06-30
Total Assets Less Current Liabilities
-77,684 GBP2024-06-30
-76,186 GBP2023-06-30
Net Assets/Liabilities
-77,684 GBP2024-06-30
-76,186 GBP2023-06-30
Equity
Called up share capital
10 GBP2024-06-30
10 GBP2023-06-30
Retained earnings (accumulated losses)
-77,694 GBP2024-06-30
-76,196 GBP2023-06-30
Equity
-77,684 GBP2024-06-30
-76,186 GBP2023-06-30
Amounts owed by group undertakings and participating interests
10 GBP2024-06-30
10 GBP2023-06-30
Other Debtors
287 GBP2024-06-30
14,888 GBP2023-06-30
Trade Creditors/Trade Payables
Amounts falling due within one year
121 GBP2024-06-30
235 GBP2023-06-30
Amounts owed to group undertakings and participating interests
Amounts falling due within one year
95,051 GBP2024-06-30
94,816 GBP2023-06-30
Other Creditors
Amounts falling due within one year
1,100 GBP2024-06-30
4,775 GBP2023-06-30

  • CLAIMONT PHARMA LTD
    Info
    CLAYMONT LIMITED - 2020-06-16
    Registered number 12588838
    9 Park Place, Newdigate Road, Harefield, Middlesex UB9 6EJ
    PRIVATE LIMITED COMPANY incorporated on 2020-05-06 (5 years 9 months). The company status is Active.
    The last date of confirmation statement was made at 2024-11-11
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 9 February 2026 and licensed under the Open Government Licence v3.0.